3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
243
Neoplasms
15
Neoplasm Metastasis
12
Carcinoma, Intraductal, Noninfiltrating
11
Breast Diseases
8
Advanced Breast Cancer
8
Breast Neoplasms, Male
7
Breast Carcinoma In Situ
7
Triple Negative Breast Neoplasms
5
Arthralgia
4
Ovarian Neoplasms
3
Neoplasms by Site
3
Breast Cancer Metastatic
3
Uterine Cervical Neoplasms
2
Recurrence
2
Patient Compliance
2
Osteoporosis
2
Obesity
2
Endometrial Neoplasms
2
Breast Neoplasm Female
2
Vitamin D Deficiency
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Skin Diseases
1
Sexual Dysfunctions, Psychological
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Nutrition Disorders
1
Interventions
Zoledronic Acid
3
Risedronic Acid
3
Letrozole
2
Exercise Movement Techniques
1
Denosumab
1
Calcium
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Diseases, Metabolic
×
Anastrozole
×
Breast
×
Clear all
NCT00082277
2011-01-26
SABRE
AstraZeneca
Phase 4
Completed
237 enrolled